Announced Thu, 25 Jun · 15:06 IST
Glenmark Pharma schedules investor meetings in London, June 30 to July 1
Board & Shareholder Meetings View source PDF
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹2184.90
prior close
₹2156.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.0-0.1—-0.1+0.8-1.4+0.1+1.2+3.3+2.1+0.6——
Up moveDown movePending
AI summary
Glenmark Pharmaceuticals has informed NSE and BSE about its schedule of analyst and institutional investor meetings. The meetings will take place in London on June 30 to July 1, 2026, in both group and one-on-one formats. The company stated no Unpublished Price Sensitive Information will be shared. The schedule is subject to change due to exigencies.
Likely market impact
Routine disclosure. No UPSI will be shared, so no near-term price catalyst from these meetings is expected.